| Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma T Bald, T Quast, J Landsberg, M Rogava, N Glodde, D Lopez-Ramos, ... Nature 507 (7490), 109-113, 2014 | 443 | 2014 |
| Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation J Landsberg, J Kohlmeyer, M Renn, T Bald, M Rogava, M Cron, M Fatho, ... Nature 490 (7420), 412-416, 2012 | 415 | 2012 |
| MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling S Huang, M Hölzel, T Knijnenburg, A Schlicker, P Roepman, U McDermott, ... Cell 151 (5), 937-950, 2012 | 365 | 2012 |
| The transcriptional program of a human B cell line in response to Myc M Schuhmacher, F Kohlhuber, M Hölzel, C Kaiser, H Burtscher, M Jarsch, ... Nucleic acids research 29 (2), 397-406, 2001 | 341 | 2001 |
| Chemotherapeutic drugs inhibit ribosome biogenesis at various levels K Burger, B Mühl, T Harasim, M Rohrmoser, A Malamoussi, M Orban, ... Journal of Biological Chemistry 285 (16), 12416-12425, 2010 | 301 | 2010 |
| Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells Y Gao, F Souza-Fonseca-Guimaraes, T Bald, SS Ng, A Young, SF Ngiow, ... Nature immunology 18 (9), 1004-1015, 2017 | 239 | 2017 |
| Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance? M Hölzel, A Bovier, T Tüting Nature Reviews Cancer 13 (5), 365-376, 2013 | 223 | 2013 |
| Stringent doxycycline-dependent control of gene activities using an episomal one-vector system GW Bornkamm, C Berens, C Kuklik-Roos, JM Bechet, G Laux, J Bachl, ... Nucleic acids research 33 (16), e137-e137, 2005 | 194 | 2005 |
| Immune cell–poor melanomas benefit from PD-1 blockade after targeted type I IFN activation T Bald, J Landsberg, D Lopez-Ramos, M Renn, N Glodde, P Jansen, ... Cancer discovery 4 (6), 674-687, 2014 | 185 | 2014 |
| The experimental power of FR900359 to study Gq-regulated biological processes R Schrage, AL Schmitz, E Gaffal, S Annala, S Kehraus, D Wenzel, ... Nature communications 6 (1), 1-17, 2015 | 184 | 2015 |
| ALK mutations conferring differential resistance to structurally diverse ALK inhibitors JM Heuckmann, M Hölzel, ML Sos, S Heynck, H Balke-Want, M Koker, ... Clinical Cancer Research 17 (23), 7394-7401, 2011 | 176 | 2011 |
| A role for c‐Myc in the regulation of ribosomal RNA processing I Schlosser, M Hölzel, M Mürnseer, H Burtscher, UH Weidle, D Eick Nucleic acids research 31 (21), 6148-6156, 2003 | 176 | 2003 |
| NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome M Hölzel, S Huang, J Koster, I Øra, A Lakeman, H Caron, W Nijkamp, ... Cell 142 (2), 218-229, 2010 | 173 | 2010 |
| Mammalian WDR12 is a novel member of the Pes1–Bop1 complex and is required for ribosome biogenesis and cell proliferation M Hölzel, M Rohrmoser, M Schlee, T Grimm, T Harasim, A Malamoussi, ... The Journal of cell biology 170 (3), 367-378, 2005 | 166 | 2005 |
| IL-36γ (IL-1F9) is a biomarker for psoriasis skin lesions AM D'erme, D Wilsmann-Theis, J Wagenpfeil, M Hölzel, S Ferring-Schmitt, ... Journal of Investigative Dermatology 135 (4), 1025-1032, 2015 | 151 | 2015 |
| ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome S Huang, J Laoukili, MT Epping, J Koster, M Hölzel, BA Westerman, ... Cancer cell 15 (4), 328-340, 2009 | 134 | 2009 |
| Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma P Falletta, L Sanchez-del-Campo, J Chauhan, M Effern, A Kenyon, ... Genes & development 31 (1), 18-33, 2017 | 132 | 2017 |
| Interdependence of Pes1, Bop1, and WDR12 controls nucleolar localization and assembly of the PeBoW complex required for maturation of the 60S ribosomal subunit M Rohrmoser, M Hölzel, T Grimm, A Malamoussi, T Harasim, M Orban, ... Molecular and cellular biology 27 (10), 3682-3694, 2007 | 127 | 2007 |
| MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment S Riesenberg, A Groetchen, R Siddaway, T Bald, J Reinhardt, D Smorra, ... Nature communications 6 (1), 1-16, 2015 | 107 | 2015 |
| Reactive neutrophil responses dependent on the receptor tyrosine kinase c-MET limit cancer immunotherapy N Glodde, T Bald, D van den Boorn-Konijnenberg, K Nakamura, ... Immunity 47 (4), 789-802. e9, 2017 | 103 | 2017 |
